94 employees
RedHill Biopharma specializes primarily in gastrointestinal and infectious diseases within the realm of specialty biopharmaceuticals.
2009
$40M
from 3 investors over 3 rounds
RedHill Biopharma Ltd. raised $40M on July 20, 2015
Investors: MLV, H.C. Wainwright & Co., LLC and ROTH Capital Partners